PMG Research and Devana Solutions have announced a long-term subscription agreement for the use of Devana's advanced cloud-based technology across PMG's network of over 50 investigative site locations. 

The agreement allows PMG's integrated network of sites to adopt Devana's Ignite for Sites platform to fully automate its operations from study lead through trial completion.

In addition to PMG's more than 7,700 completed clinical trials, the advanced Devana Solutions technology simultaneously tracks, aggregates and allows PMG to display and report its timing and performance metrics in real-time for all trials currently running across its entire site network.

This technology advantage, coupled with best-in-class trial management capabilities, will allow PMG Research to expand its industry leading position and secure additional trials in partnership with pharmaceutical sponsors and CROs.

Amanda Wright, senior director of Client Services and Communications at PMG, commented, "PMG Research has always embraced technology innovation as an important way to grow our business and to fulfill the organization's mission of bringing clinical research to as many people as possible.

"Devana Solutions system allows for the end-to-end capture of data that will us to continue to demonstrate to CROs and Sponsors that our performance is among the best in the industry and that PMG is committed to the highest standards."

Barry Lake, CEO & executive chairman of Devana, added, "PMG is clearly a leader in the site operations enterprise and we are thrilled to partner with them.

"From the first conversation, they shared Devana Solutions' opinion that more and better data about site performance will mean that the most capable networks of sites, like PMG Research, will win more awards, leading to shorter cycle times for trials, lower costs and, ultimately, lower cost treatments for patients."